Travere Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-3.4M | $-4.9M | $1.4M | $29.1M |
| FY2017 | $7.4M | $6.5M | $887.0K | $26.9M |
| FY2018 | $-25.0M | $-25.7M | $727.0K | $19.8M |
| FY2019 | $-58.2M | $-58.4M | $195.0K | $21.1M |
| FY2020 | $-42.7M | $-49.5M | $6.8M | $23.6M |
| FY2021 | $-14.8M | $-19.9M | $5.1M | $29.6M |
| FY2022 | $-186.3M | $-186.5M | $191.0K | $38.1M |
| FY2023 | $-280.0M | $-280.7M | $668.0K | $44.2M |
| FY2024 | $-237.5M | $-237.5M | — | $36.9M |
| FY2025 | $37.8M | $37.8M | — | $44.9M |